Developmental Therapeutics

The Developmental Therapeutics program focuses on developing hypotheses and evidenced-based translational strategies for improved cancer treatment. Emphasis is placed on technology associated with the discovery and development of small molecule drug agents and biological therapies followed by validation using preclinical and clinical models.

Our objective is to optimize therapies through the generation, integration and translation of scientific information between the bench and the bedside, the patient and the population. Program members have a wide range of expertise and practical experience in applying for Investigational New Drug (IND) applications and conducting IND studies and clinical trials.

Program Leader

Hong-Yu Li, Ph.D.
Hong-Yu Li, Ph.D.